CN100384987C - A method for expanding hematopoietic stem cells under three-dimensional conditions - Google Patents
A method for expanding hematopoietic stem cells under three-dimensional conditions Download PDFInfo
- Publication number
- CN100384987C CN100384987C CNB2006100768613A CN200610076861A CN100384987C CN 100384987 C CN100384987 C CN 100384987C CN B2006100768613 A CNB2006100768613 A CN B2006100768613A CN 200610076861 A CN200610076861 A CN 200610076861A CN 100384987 C CN100384987 C CN 100384987C
- Authority
- CN
- China
- Prior art keywords
- cells
- stem cells
- hematopoietic stem
- microgel beads
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000003958 hematopoietic stem cell Anatomy 0.000 title claims abstract description 73
- 238000000034 method Methods 0.000 title claims abstract description 23
- 210000004027 cell Anatomy 0.000 claims abstract description 88
- 239000011324 bead Substances 0.000 claims abstract description 73
- 239000000648 calcium alginate Substances 0.000 claims abstract description 40
- 235000010410 calcium alginate Nutrition 0.000 claims abstract description 40
- 229960002681 calcium alginate Drugs 0.000 claims abstract description 40
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims abstract description 40
- 210000002993 trophoblast Anatomy 0.000 claims abstract description 34
- 238000003306 harvesting Methods 0.000 claims abstract description 13
- 239000000725 suspension Substances 0.000 claims abstract description 9
- 238000002955 isolation Methods 0.000 claims abstract description 7
- 210000001185 bone marrow Anatomy 0.000 claims description 33
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims description 32
- 210000004700 fetal blood Anatomy 0.000 claims description 31
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 28
- 239000002609 medium Substances 0.000 claims description 22
- 210000005087 mononuclear cell Anatomy 0.000 claims description 16
- 239000001963 growth medium Substances 0.000 claims description 15
- 230000003068 static effect Effects 0.000 claims description 13
- 239000006285 cell suspension Substances 0.000 claims description 11
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 9
- 230000002572 peristaltic effect Effects 0.000 claims description 9
- 210000000130 stem cell Anatomy 0.000 claims description 8
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 239000007789 gas Substances 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000000661 sodium alginate Substances 0.000 claims description 6
- 235000010413 sodium alginate Nutrition 0.000 claims description 6
- 229940005550 sodium alginate Drugs 0.000 claims description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 4
- 238000006213 oxygenation reaction Methods 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 3
- 102000004142 Trypsin Human genes 0.000 claims description 3
- 108090000631 Trypsin Proteins 0.000 claims description 3
- 239000012091 fetal bovine serum Substances 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 210000002303 tibia Anatomy 0.000 claims description 3
- 239000012588 trypsin Substances 0.000 claims description 3
- 210000000689 upper leg Anatomy 0.000 claims description 3
- 238000009413 insulation Methods 0.000 claims description 2
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 239000013589 supplement Substances 0.000 claims description 2
- 230000004927 fusion Effects 0.000 claims 1
- 238000010899 nucleation Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 abstract description 12
- 230000012010 growth Effects 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 6
- 239000003102 growth factor Substances 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 2
- 239000011148 porous material Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 20
- 238000000338 in vitro Methods 0.000 description 15
- 210000002536 stromal cell Anatomy 0.000 description 13
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 11
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 11
- 238000003501 co-culture Methods 0.000 description 10
- 210000001178 neural stem cell Anatomy 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 5
- 229920001917 Ficoll Polymers 0.000 description 5
- 210000000963 osteoblast Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 3
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 3
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 3
- 238000011072 cell harvest Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000002055 immunohistochemical effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 210000002747 omentum Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108010002386 Interleukin-3 Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 102000008730 Nestin Human genes 0.000 description 1
- 108010088225 Nestin Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000000432 density-gradient centrifugation Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 210000002360 granulocyte-macrophage progenitor cell Anatomy 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000005055 nestin Anatomy 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 230000001573 trophoblastic effect Effects 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明属于生物技术与组织工程领域,特别涉及一种三维条件下两种细胞共培养的方法。其特征是用海藻酸钙微胶珠将滋养细胞包埋起来,然后在旋转壁式生物反应器中将包埋的滋养细胞与造血干细胞进行共同培养,收获造血干细胞与滋养细胞。本发明的效果和益处是,微胶珠的孔道可以使滋养细胞分泌的重要生长因子透过微胶珠滋养外部的造血干细胞,同时微胶珠有效地隔开了两种不同来源的细胞,不但起到免疫隔离的作用,还有利于分离、收获这两种细胞;旋转壁式生物反应器为造血干细胞提供了三维悬浮生长环境,有效降低了对造血干细胞的剪切力,有利于造血干细胞的扩增。
The invention belongs to the fields of biotechnology and tissue engineering, in particular to a method for co-cultivating two kinds of cells under three-dimensional conditions. The method is characterized in that the trophoblasts are embedded with calcium alginate microgel beads, and then the embedded trophoblasts and hematopoietic stem cells are co-cultured in a rotating wall bioreactor to harvest the hematopoietic stem cells and the trophoblasts. The effects and benefits of the present invention are that the pores of the microgel beads can allow the important growth factors secreted by the trophoblasts to pass through the microgel beads to nourish the external hematopoietic stem cells, and at the same time the microgel beads effectively separate the cells of two different sources, not only It plays the role of immune isolation, and is also conducive to the separation and harvest of these two types of cells; the rotating wall bioreactor provides a three-dimensional suspension growth environment for hematopoietic stem cells, which effectively reduces the shear force on hematopoietic stem cells and is conducive to the growth of hematopoietic stem cells. Amplify.
Description
技术领域 technical field
本发明属于生物技术与组织工程领域,特别涉及一种三维条件下扩增造血干细胞的方法。The invention belongs to the fields of biotechnology and tissue engineering, in particular to a method for expanding hematopoietic stem cells under three-dimensional conditions.
背景技术 Background technique
细胞处于体内复杂的生长环境中,不同种类的细胞之间存在着重要的联系,有些细胞体外培养时在不同程度上需要依赖另外一些细胞对它们的滋养、支持作用,前者称为被滋养细胞,后者称为滋养细胞。这种滋养作用对于干细胞的体外培养来说尤为重要,如造血干细胞的体外培养。Cells are in a complex growth environment in the body, and there are important connections between different types of cells. Some cells need to rely on other cells to nourish and support them to varying degrees when cultured in vitro. The former are called trophoblast cells. The latter are called trophoblasts. This trophic effect is particularly important for the in vitro culture of stem cells, such as the in vitro culture of hematopoietic stem cells.
造血干细胞在临床上有广泛的应用前景,它可以重建高剂量放化疗后病人的造血系统、进行基因治疗及免疫治疗、制备成熟血液产品等。但是在实际应用中存在造血干细胞的数量限制问题,需要大规模扩增。目前模拟体内微环境已经被认为是体外扩增造血干细胞的最佳方法。基质细胞是一类能够对造血干细胞起到滋养作用的滋养细胞,多种基质细胞系已经被用来支持造血干细胞的体外扩增。它们可以分泌多种已知的、未知的生长因子来维持和扩增造血干细胞,避免造血干细胞在体外培养过程中逐渐分化和凋亡。Hematopoietic stem cells have broad clinical application prospects. They can rebuild the hematopoietic system of patients after high-dose radiotherapy and chemotherapy, perform gene therapy and immunotherapy, and prepare mature blood products. However, in practical applications, there is a limitation on the number of hematopoietic stem cells, which requires large-scale expansion. Simulating the in vivo microenvironment has been considered as the best method to expand hematopoietic stem cells in vitro. Stromal cells are a kind of trophoblast cells that can nourish hematopoietic stem cells, and a variety of stromal cell lines have been used to support the expansion of hematopoietic stem cells in vitro. They can secrete a variety of known and unknown growth factors to maintain and expand hematopoietic stem cells, and avoid the gradual differentiation and apoptosis of hematopoietic stem cells during in vitro culture.
在实现两种细胞共培养的手段上,大部分研究都采用了基质细胞与造血干细胞直接接触共培养的方法,即首先在培养器皿底部铺设基质细胞层,然后使用一定剂量的放射线照射基质细胞来抑制基质细胞的活性,再将造血干细胞在基质细胞层上进行培养。这种直接接触的培养方法能够支持滋养造血干细胞,促进造血干细胞的扩增,但还会使部分造血干细胞粘附在基质细胞上,不利于两种细胞的分离与收获;如果是异源的两种细胞接触,还存在免疫排斥问题。目前,体外培养的造血干细胞输入人体之前,基质细胞必须要完全与造血干细胞分离,以保证植入的生物安全性。尽管有的研究者使用小孔径的网膜等将共培养体系中的这两种细胞隔开,在一定程度上改善了细胞分离的问题,如Kawada等(Experimental Hematology,27,904,1999)使用一种多孔膜将脐带血CD34+细胞与鼠基质细胞隔开,但这两种细胞的绒毛还是能够通过多孔网膜直接接触,免疫问题还是存在。因此需要开发新的共培养中隔离异源细胞的方法。In terms of the means of co-cultivation of two kinds of cells, most studies have adopted the method of direct contact co-cultivation of stromal cells and hematopoietic stem cells, that is, first laying a layer of stromal cells on the bottom of the culture vessel, and then irradiating the stromal cells with a certain dose of radiation. Inhibit the activity of stromal cells, and then culture hematopoietic stem cells on the stromal cell layer. This direct contact culture method can support the nourishment of hematopoietic stem cells and promote the expansion of hematopoietic stem cells, but it will also make some hematopoietic stem cells adhere to the stromal cells, which is not conducive to the separation and harvest of the two cells; There is also the problem of immune rejection. At present, before the hematopoietic stem cells cultured in vitro are transfused into the human body, the stromal cells must be completely separated from the hematopoietic stem cells to ensure the biosafety of the implantation. Although some researchers use small-diameter omentum to separate the two types of cells in the co-culture system, which improves the problem of cell separation to a certain extent, such as Kawada et al. (Experimental Hematology, 27, 904, 1999) used A porous membrane separates the cord blood CD34 + cells from the murine stromal cells, but the villi of these two types of cells are still able to directly contact through the porous omentum, and the immune problem still exists. There is therefore a need to develop new methods for isolating heterologous cells in co-cultures.
另外,目前大多数基质细胞和造血干细胞的共培养都是在静态的培养条件下进行的,如使用孔板或培养瓶。静态培养尽管简便,但是存在以下弊端:In addition, most of the current co-culture of stromal cells and hematopoietic stem cells is carried out under static culture conditions, such as using well plates or culture flasks. Although static culture is convenient, it has the following disadvantages:
1)培养液缺乏有效混合而导致细胞因子等营养成分、溶解氧、代谢产物等物质以及pH值在培养基中形成浓度梯度;1) The lack of effective mixing of the culture medium leads to the formation of a concentration gradient in the culture medium of nutrients such as cytokines, dissolved oxygen, metabolites and other substances, as well as pH values;
2)静态培养系统的各种参数一般都难以在线监测和控制;2) Various parameters of the static culture system are generally difficult to monitor and control online;
3)需要人工换液等操作,增加污染的危险性;3) Operations such as manual fluid change are required, increasing the risk of contamination;
4)二维静态培养远离人体内的三维生长环境,在一定程度上易造成干/祖细胞的分化。4) The two-dimensional static culture is far away from the three-dimensional growth environment in the human body, which is easy to cause the differentiation of stem/progenitor cells to a certain extent.
因此,需要发展适宜的三维动态共培养体系,来改善培养环境以制备出数量和质量均有保证的造血干细胞。经常用于基质细胞和造血干细胞共培养的灌注式(Palsson等,Bio/Technology,11,368,1993)及固定床式生物反应器(Meissner等,Cytotechnology,30,227,1999),由于它们内部的流体剪切力较大,基质细胞和造血干细胞相互作用程度有限,扩增造血干细胞的效果不佳。Therefore, it is necessary to develop a suitable three-dimensional dynamic co-culture system to improve the culture environment to prepare hematopoietic stem cells with guaranteed quantity and quality. Perfusion (Palsson et al., Bio/Technology, 11, 368, 1993) and fixed-bed bioreactors (Meissner et al., Cytotechnology, 30, 227, 1999) that are often used for co-cultivation of stromal cells and hematopoietic stem cells, due to their internal The fluid shear force is relatively large, the degree of interaction between stromal cells and hematopoietic stem cells is limited, and the effect of expanding hematopoietic stem cells is not good.
发明内容 Contents of the invention
本发明的目的是提供一种三维条件下扩增造血干细胞的方法。The purpose of the present invention is to provide a method for expanding hematopoietic stem cells under three-dimensional conditions.
本发明的技术方案包括以下步骤:Technical scheme of the present invention comprises the following steps:
1.提供滋养细胞。取四周龄体重2.5kg左右的新西兰大白兔,注射空气法处死,取出股骨和胫骨,浸泡在75%的酒精中30分钟,转移至无菌超净台内。用骨钳剪开骨两端,PBS冲洗骨髓腔,冲出骨髓。加无血清DMEM培养基稀释,1200rpm离心10分钟。弃脂肪层,加无血清DMEM培养基稀释。然后与Ficoll细胞分离液按1∶1体积比混合,3000rpm离心30分钟。吸取界面层,加入无血清DMEM培养基清洗2次,1200rpm离心5分钟。去上清,加入含20%胎牛血清的DMEM培养基,调整细胞浓度,以5×105cells·cm-2的密度接种于培养瓶中。三天后去除悬浮细胞,每五天半量换液。当原代兔骨髓间充质干细胞在培养瓶底达到80%融合时候,加入浓度为0.05%的胰酶(含0.02%EDTA)消化,按1∶3的比例进行传代培养。1. Provide trophoblasts. New Zealand white rabbits weighing about 2.5kg at four weeks old were killed by air injection, the femur and tibia were taken out, soaked in 75% alcohol for 30 minutes, and transferred to a sterile ultra-clean bench. Cut both ends of the bone with bone forceps, rinse the bone marrow cavity with PBS, and flush out the bone marrow. Add serum-free DMEM medium to dilute, and centrifuge at 1200rpm for 10 minutes. Discard the fat layer and add serum-free DMEM medium to dilute. Then it was mixed with Ficoll cell separation solution at a volume ratio of 1:1, and centrifuged at 3000 rpm for 30 minutes. Aspirate the interface layer, add serum-free DMEM medium to wash twice, and centrifuge at 1200rpm for 5 minutes. Remove the supernatant, add DMEM medium containing 20% fetal calf serum, adjust the cell concentration, and inoculate in a culture flask at a density of 5×10 5 cells·cm -2 . After three days, the suspended cells were removed, and the medium was changed every five days in half. When the primary rabbit bone marrow mesenchymal stem cells reached 80% confluence at the bottom of the culture flask, they were digested with 0.05% trypsin (containing 0.02% EDTA) and subcultured at a ratio of 1:3.
2.海藻酸钙微胶珠包埋滋养细胞。制备密度为2.5×105cells·mL-1的第四代兔骨髓间充质干细胞悬液,与1.5%的海藻酸钠溶液以1∶4体积比混合均匀,经5#针头逐滴滴加到1.5%氯化钙溶液中,不断搅拌,反应10分钟,用20目筛网过滤得到微胶珠,PBS洗涤三次,得到直径为2毫米的包埋有兔骨髓间充质干细胞的海藻酸钙微胶珠。制备小直径的微胶珠要增加使用高压静电发生器,其制备过程如图2所示,其中,海藻酸钙微胶珠的直径大小主要由针尖直径、电压、两极间距离以及海藻酸钠液滴流速来控制。2. Calcium alginate microgel beads embed trophoblasts. Prepare the fourth-generation rabbit bone marrow mesenchymal stem cell suspension with a density of 2.5×10 5 cells mL -1 , mix it with 1.5% sodium alginate solution at a volume ratio of 1:4, and add it drop by drop through a 5 # needle Add to 1.5% calcium chloride solution, stir continuously, react for 10 minutes, filter with 20 mesh screen to obtain microgel beads, wash with PBS three times, and obtain calcium alginate with a diameter of 2 mm and embedding rabbit bone marrow mesenchymal stem cells Microgel beads. The preparation of small-diameter microgel beads requires the use of a high-voltage electrostatic generator. The preparation process is shown in Figure 2, wherein the diameter of the calcium alginate microgel beads is mainly determined by the diameter of the needle tip, voltage, distance between the two electrodes, and sodium alginate solution. Droplet flow rate to control.
3.分离人脐带血单个核细胞。脐带血来自健康产妇足月分娩或足月剖腹产婴儿,每次原血采集量平均为50~100mL。脐带血采集后用密度为1.077g·mL-1的Ficoll细胞分离液密度梯度离心后获得单个核细胞,Ficoll分离液与脐带血的体积比例为1∶1~1∶2。分离后的细胞用IMDM基础培养基离心洗涤两次(1000rpm,5min),调整细胞密度备用。3. Isolation of human umbilical cord blood mononuclear cells. Umbilical cord blood comes from healthy puerpera who gave birth at term or infants who delivered at term by caesarean section, and the average amount of raw blood collected each time was 50-100 mL. After the cord blood was collected, mononuclear cells were obtained by density gradient centrifugation with Ficoll cell separation medium with a density of 1.077 g·mL -1 . The volume ratio of Ficoll separation medium to cord blood was 1:1-1:2. The separated cells were centrifuged and washed twice with IMDM basal medium (1000 rpm, 5 min), and the cell density was adjusted for later use.
4.准备旋转壁式生物反应器。旋转壁式生物反应器(rotating wall vessel,RWV)主要由两个循环回路构成:(1)培养基循环回路;(2)气体循环回路。具体地,培养基循环为:培养基通过蠕动泵11送到充氧器10中充氧,之后由RWV左端进料口进入培养室13为细胞提供养分,氧含量降低了的培养基从RWV右端出料口进入蠕动泵11,再送入充氧器10中充氧,开始下一轮循环。气体循环为:CO2培养箱8中含5%CO295%空气的气体由气泵9送入充氧器10中为培养基补充氧,然后返回CO2培养箱8中,不断循环。RWV主体部分充氧器10与培养室13放置在CO2培养箱8外的保温罩15中。实验之前,使用清洗剂及软刷清洗RWV的各个部件后,超纯水冲洗三遍。然后将各个部件浸泡在75%的酒精溶液中过夜,再用超纯水冲洗三遍。装配好RWV保温罩15中的主体部分,将主体部分及连接好的外管路、充氧器分别包裹并高压灭菌(121℃,30min),烘干备用。4. Prepare the rotating wall bioreactor. A rotating wall vessel (RWV) is mainly composed of two circulation loops: (1) medium circulation loop; (2) gas circulation loop. Specifically, the circulation of the culture medium is: the culture medium is sent to the
5.在旋转壁式生物反应器中,三维悬浮共培养海藻酸钙微胶珠包埋的滋养细胞与造血干细胞。在超净台中无菌条件下组装RWV培养系统,注满无菌PBS循环一小时,放出PBS,注入培养液,打开控制台12中的温控开关将温度控制在37℃。将密度为2~5×105cells·mL-1的人脐带血单个核细胞和海藻酸钙微胶珠包埋的滋养细胞悬液接种至RWV培养室13中,盖好保温罩15,开启蠕动泵11和气泵9。一小时后,打开控制台12中可调速电动机14的电源开关,通过调节旋钮使RWV培养室13的内外筒同方向同角速度旋转起来,此时整个系统开始工作。培养室13的转速是逐步增加的,经过3rpm一小时,5rpm十二小时,最终达到并保持在6rpm,使细胞和微胶珠充分地悬浮起来。5. In a rotating wall bioreactor, trophoblast cells embedded in calcium alginate microgel beads and hematopoietic stem cells were co-cultured in three-dimensional suspension. Assemble the RWV culture system under aseptic conditions in the ultra-clean bench, fill with sterile PBS and circulate for one hour, release the PBS, inject the culture solution, turn on the temperature control switch in the
6.分离造血干细胞与微胶珠,收获造血干细胞。共培养结束后,用注射器抽出反应器培养室13中的悬液,将悬液滴加在高温灭菌后的20目不锈钢筛网上,筛网下方放置无菌的小烧杯。微胶珠被截留在筛网上,而造血干细胞悬液则透过筛网进入烧杯中。将烧杯中的造血干细胞悬液1000rpm离心5分钟,弃上清,加入1毫升培养液,吹打,计数,接种至培养瓶中培养。6. Separate hematopoietic stem cells and microgel beads, and harvest hematopoietic stem cells. After the co-cultivation is over, the suspension in the
7.溶解微胶珠,收获滋养细胞。将收获到的微胶珠用PBS冲洗三次,浸泡在浓度为55mM的柠檬酸钠溶液中,反应10分钟,1500rpm离心10分钟,弃上清,再加入1毫升培养液,吹打,计骨髓间充质干细胞数,接种至培养瓶中培养。7. Dissolve microgel beads and harvest trophoblasts. The harvested microgel beads were rinsed three times with PBS, soaked in a sodium citrate solution with a concentration of 55mM, reacted for 10 minutes, centrifuged at 1500rpm for 10 minutes, discarded the supernatant, then added 1ml of culture medium, pipetted, and counted bone marrow mesenchymal cells. The number of mesenchymal stem cells was inoculated into culture flasks for culture.
本发明的效果和优点是:Effect and advantage of the present invention are:
(1)能够使滋养细胞和造血干细胞在三维条件下进行共培养,以发挥滋养细胞对造血干细胞的滋养、支持作用。(1) The trophoblasts and hematopoietic stem cells can be co-cultured under three-dimensional conditions, so as to exert the nourishing and supporting effect of the trophoblasts on the hematopoietic stem cells.
(2)能够隔离开共培养的两种细胞以避免它们之间的免疫排斥作用,有利于共培养后这两种细胞的分离与收获。(2) The two kinds of co-cultured cells can be isolated to avoid immune rejection between them, which is beneficial to the separation and harvest of the two kinds of cells after co-cultured.
(3)旋转壁式生物反应器显著降低了细胞生长环境的剪切力,使细胞始终处于三维动态条件下生长,提高了细胞的培养效果。(3) The rotating wall bioreactor significantly reduces the shear force of the cell growth environment, makes the cells grow under three-dimensional dynamic conditions all the time, and improves the cell culture effect.
(4)利用本发明一种三维条件下扩增造血干细胞的方法,对海藻酸钙微胶珠包埋的兔骨髓间充质干细胞与人脐血造血干细胞进行了动态共培养。结果表明,这两种细胞在此培养体系中均生长良好,七天后有核细胞、CD34+细胞及粒单系祖细胞(colony-forming unit-granulocyte macrophage,CFU-GM)的扩增倍数分别可达170倍、24倍和14倍。(4) Using a method for amplifying hematopoietic stem cells under three-dimensional conditions of the present invention, dynamic co-cultivation of rabbit bone marrow mesenchymal stem cells embedded in calcium alginate microgel beads and human umbilical cord blood hematopoietic stem cells was carried out. The results showed that these two kinds of cells grew well in this culture system, and after seven days, the expansion folds of nucleated cells, CD34 + cells and myelomonocytic progenitor cells (colony-forming unit-granulocyte macrophage, CFU-GM) were respectively Up to 170 times, 24 times and 14 times.
附图说明 Description of drawings
图1是本发明所述的一种三维条件下扩增造血干细胞的方法操作流程图。Fig. 1 is a flowchart of the operation of a method for expanding hematopoietic stem cells under three-dimensional conditions according to the present invention.
图2是本发明所述的一种三维条件下扩增造血干细胞的方法制备海藻酸钙微胶珠的示意图。Fig. 2 is a schematic diagram of preparation of calcium alginate microgel beads by a method for expanding hematopoietic stem cells under three-dimensional conditions according to the present invention.
图3是本发明所述的一种三维条件下扩增造血干细胞的方法给细胞和微胶珠提供三维悬浮生长环境的旋转式细胞培养系统工艺流程图。Fig. 3 is a process flow diagram of a rotary cell culture system that provides a three-dimensional suspension growth environment for cells and microgel beads in a method for expanding hematopoietic stem cells under three-dimensional conditions according to the present invention.
图4是本发明所述的一种三维条件下扩增造血干细胞的方法滋养细胞和造血干细胞共培养示意图。Fig. 4 is a schematic diagram of co-culture of trophoblasts and hematopoietic stem cells in a method for expanding hematopoietic stem cells under three-dimensional conditions according to the present invention.
图5是本发明所述的一种三维条件下扩增造血干细胞的方法静态条件下,海藻酸钙微胶珠(直径为2毫米)包埋小鼠神经干细胞的显微照片(A:Day 0;B:Day 9)。Fig. 5 is a method for expanding hematopoietic stem cells under a three-dimensional condition of the present invention under static conditions, a microphotograph of calcium alginate microgel beads (2 mm in diameter) embedding mouse neural stem cells (A: Day 0 ; B: Day 9).
图6是本发明所述的一种三维条件下扩增造血干细胞的方法静态条件下,海藻酸钙微胶珠(直径为2毫米)包埋小鼠颅骨成骨细胞的显微照片。Fig. 6 is a micrograph of calcium alginate microgel beads (2 mm in diameter) embedding mouse calvarial osteoblasts under static conditions in a method for expanding hematopoietic stem cells under three-dimensional conditions according to the present invention.
图7是本发明所述的一种三维条件下扩增造血干细胞的方法静态条件下,包埋兔骨髓间充质干细胞的海藻酸钙微胶珠(直径为2毫米)和人脐带血造血干细胞共培养168hr时的显微照片(A:100×;B:200×)。Figure 7 is a method for expanding hematopoietic stem cells under a three-dimensional condition according to the present invention. Under static conditions, calcium alginate microgel beads (2 mm in diameter) embedding rabbit bone marrow mesenchymal stem cells and human umbilical cord blood hematopoietic stem cells Micrographs of co-cultivation for 168 hr (A: 100×; B: 200×).
图中:1.注射器;2.烧杯;3.转子;4.铁架台;5.阳极;6.阴极;7.高压静电发生器;8.CO2培养箱;9.气泵;10.充氧器;11.蠕动泵;12.控制台;13.培养室;14.可调速电动机;15.保温罩;16.旋转式细胞培养系统培养室的外筒;17.旋转式细胞培养系统培养室的内筒;18.包埋有滋养细胞的海藻酸钙微胶珠和微胶珠外近距离相互作用的造血干细胞;19.微胶珠外的造血干细胞;20.包埋在微胶珠内的滋养细胞。In the figure: 1. Syringe; 2. Beaker; 3. Rotor; 4. Iron stand; 5. Anode; 6. Cathode; 7. High-voltage electrostatic generator; 8. CO 2 incubator; 9. Air pump; 10.
具体实施方式 Detailed ways
以下结合技术方案和附图详细叙述本发明的具体实施例。Specific embodiments of the present invention will be described in detail below in conjunction with technical solutions and accompanying drawings.
实施例1:Example 1:
本实施例为海藻酸钙微胶珠包埋小鼠神经干细胞体外培养及鉴定。This example is the in vitro culture and identification of mouse neural stem cells embedded in calcium alginate microgel beads.
为了验证细胞可以在海藻酸钙微胶珠中良好生长,采用直径为2毫米的海藻酸钙微胶珠包埋小鼠神经干细胞,进行体外培养与鉴定。具体地,制备第六代小鼠神经干细胞悬液,细胞总数为9×105个,细胞密度调整为4×105cells·mL-1。将此细胞悬液与1.5%海藻酸钠溶液以1∶4的体积比混合均匀(此时细胞密度为0.8×105cells·mL-1),通过5#针头逐滴滴加到1.5%CaCl2溶液中,搅拌条件下反应10分钟,PBS洗涤三次,使用筛网过滤则得到微胶珠。将这些微胶珠平均分为三份,接种于装有3毫升培养液的培养瓶中培养。另取一份同样细胞总数的小鼠神经干细胞悬液,平均分成三份,不用微胶珠包埋,以1×105cells·mL-1的密度接种于装有3毫升培养液的培养瓶中,作为对照组进行静态培养。In order to verify that cells can grow well in calcium alginate microgel beads, mouse neural stem cells were embedded in calcium alginate microgel beads with a diameter of 2 mm, and cultured and identified in vitro. Specifically, the sixth-generation mouse neural stem cell suspension was prepared, the total number of cells was 9×10 5 , and the cell density was adjusted to 4×10 5 cells·mL -1 . Mix this cell suspension with 1.5% sodium alginate solution at a volume ratio of 1:4 (the cell density at this time is 0.8×10 5 cells·mL -1 ), and add dropwise to 1.5% CaCl through a 5 # needle 2 solution, reacted for 10 minutes under stirring conditions, washed three times with PBS, and filtered through a sieve to obtain microgel beads. These microgel beads were equally divided into three parts and inoculated into culture flasks containing 3 ml of culture solution for culture. Take another mouse neural stem cell suspension with the same total number of cells, divide it into three parts evenly, and inoculate it in a culture bottle containing 3 ml of culture medium at a density of 1×10 5 cells·mL -1 without embedding with microgel beads In , static culture was performed as a control group.
培养7天以后,用55mM柠檬酸钠溶液溶解海藻酸钙微胶珠,反应10分钟,1500rpm离心10分钟,弃上清,加入1毫升培养基,吹打,计数,免疫组化鉴定。同时收获对照组的神经干细胞,消化,吹打,计数,免疫组化鉴定。After culturing for 7 days, dissolve the calcium alginate microgel beads with 55mM sodium citrate solution, react for 10 minutes, centrifuge at 1500rpm for 10 minutes, discard the supernatant, add 1ml of medium, pipette, count, and immunohistochemical identification. At the same time, the neural stem cells in the control group were harvested, digested, pipetted, counted, and identified by immunohistochemistry.
以上实验均重复三次。The above experiments were repeated three times.
实验结果:培养7天后,对照组细胞密度达2×105cells·mL-1,扩增倍数为2倍;海藻酸钙微胶珠包埋组细胞密度达1.58×105cells·mL-1,扩增倍数为1.98倍。免疫组化鉴定发现微胶珠内的神经干细胞与对照组神经干细胞一样,都能够表达Nestin,并且能够向神经元和胶质细胞分化。图5为海藻酸钙微胶珠(直径为2毫米)包埋小鼠神经干细胞的显微照片(A:Day 0;B:Day 9)。Experimental results: After 7 days of culture, the cell density of the control group reached 2×10 5 cells·mL -1 , and the amplification factor was 2 times; the cell density of the calcium alginate microgel beads embedding group reached 1.58×10 5 cells·mL -1 , the amplification factor was 1.98 times. Immunohistochemical identification revealed that the neural stem cells in the microgel beads, like the control neural stem cells, could express Nestin and differentiate into neurons and glial cells. Fig. 5 is a photomicrograph of calcium alginate microgel beads (2 mm in diameter) embedding mouse neural stem cells (A: Day 0; B: Day 9).
此实施例说明:细胞在海藻酸钙微胶珠中能够良好生长;静态培养条件下,微胶珠内培养与普通培养的细胞生长情况大致相同,同时验证了海藻酸钙微胶珠的传质性能良好;由于神经干细胞对剪切力十分敏感,提示在动态条件下,微胶珠内培养细胞可能会增殖更多。This example shows that cells can grow well in calcium alginate microgel beads; under static culture conditions, the growth of cells cultured in microgel beads is roughly the same as that of ordinary cultured cells, and at the same time, the mass transfer of calcium alginate microgel beads is verified The performance is good; since neural stem cells are very sensitive to shear force, it is suggested that under dynamic conditions, cells cultured in microgel beads may proliferate more.
实施例2:Example 2:
本实施例为海藻酸钙微胶珠包埋小鼠颅骨成骨细胞细胞时的破囊收获率。This example is the capsule-breaking harvest rate when calcium alginate microgel beads embed mouse calvarial osteoblast cells.
使用直径为2毫米的海藻酸钙微胶珠包埋小鼠颅骨成骨细胞,通过柠檬酸钠溶液溶解微胶珠来确定细胞的收获率。具体地,将1毫升密度为6×105cells·mL-1小鼠颅骨成骨细胞与4毫升1.5%海藻酸钠溶液混合均匀,通过5#针头逐滴滴加到1.5%CaCl2溶液中,搅拌条件下反应10分钟,PBS洗涤三次。加入55mM柠檬酸钠溶液作用10分钟,1500rpm离心10分钟,弃上清,加入1毫升培养基,吹打,计数,计算细胞收获率。Calcium alginate microgel beads with a diameter of 2 mm were used to embed mouse calvarial osteoblasts, and the cell harvest rate was determined by dissolving the beads with sodium citrate solution. Specifically, mix 1 ml of mouse calvarial osteoblasts with a density of 6×10 5 cells·mL -1 with 4 ml of 1.5% sodium alginate solution, and add it dropwise into the 1.5% CaCl 2 solution through a 5 # needle , reacted for 10 minutes under stirring conditions, and washed three times with PBS. Add 55 mM sodium citrate solution for 10 minutes, centrifuge at 1500 rpm for 10 minutes, discard the supernatant, add 1 ml of medium, pipette, count, and calculate the cell harvest rate.
以上实验重复三次。The above experiments were repeated three times.
实验结果:三次实验所得细胞收获率分别为86.7%,79.2%,96.4%,平均收获率达到87.4%。此实施例说明:采用柠檬酸钠溶解微胶珠收获细胞的方法是可行的;在细胞共培养后,可以通过该方法收获大部分的滋养细胞。图6为海藻酸钙微胶珠(直径为2毫米)包埋小鼠颅骨成骨细胞的显微照片。Experimental results: The cell harvest rates obtained in the three experiments were 86.7%, 79.2%, and 96.4%, respectively, and the average harvest rate reached 87.4%. This example illustrates that the method of harvesting cells by dissolving microgel beads with sodium citrate is feasible; after cell co-cultivation, most of the trophoblasts can be harvested by this method. Figure 6 is a photomicrograph of calcium alginate microgel beads (2 mm in diameter) embedding mouse calvarial osteoblasts.
实施例3:Example 3:
本实施例为人脐带血造血干细胞在旋转壁式生物反应器内的培养。This example is the cultivation of human umbilical cord blood hematopoietic stem cells in a rotating wall bioreactor.
为了验证RWV培养系统能够培养对生长环境较敏感的干细胞,本实施例使用人脐带血造血干细胞在RWV培养系统内进行培养。In order to verify that the RWV culture system can cultivate stem cells that are more sensitive to the growth environment, in this example, human umbilical cord blood hematopoietic stem cells were cultured in the RWV culture system.
人脐带血单个核细胞的分离:脐带血来自健康产妇足月分娩或足月剖腹产婴儿,每次原血采集量平均为50~100mL。脐带血采集后用密度为1.077g·mL-1的Ficoll淋巴细胞分离液密度梯度离心(2500r/min,25min),离心获得单个核细胞(含有1%左右的CD34+细胞)后用IMDM基础培养基离心洗涤两次(1000rpmin,5min)备用。Isolation of mononuclear cells from human umbilical cord blood: umbilical cord blood comes from healthy mothers who gave birth at term or infants born at term by caesarean section, and the average amount of raw blood collected each time is 50-100mL. After the umbilical cord blood was collected, it was centrifuged with Ficoll lymphocyte separation medium with a density of 1.077g·mL -1 (2500r/min, 25min) to obtain mononuclear cells (containing about 1% CD34 + cells) and then cultured with IMDM The base was centrifuged and washed twice (1000rpmin, 5min) for later use.
实验前生物反应器的准备:使用清洗剂及软刷清洗RWV的各个部件后,超纯水冲洗三遍。将各个部件浸泡在75%的酒精溶液中过夜,再用超纯水冲洗三遍。装配好RWV的主体部分,将主体部分及连接好的外管路、充氧器分别包裹并高压灭菌(121℃,30min),烘干备用。Preparation of the bioreactor before the experiment: After cleaning each part of the RWV with a cleaning agent and a soft brush, rinse it three times with ultrapure water. Each part was soaked overnight in 75% alcohol solution and rinsed three times with ultrapure water. Assemble the main part of the RWV, wrap the main part, the connected external pipeline, and the oxygenator separately and autoclave (121°C, 30min), dry for later use.
造血干细胞在反应器内的接种及培养:打开温控开关,将保温罩内RWV主体部分温度控制在37℃,人脐带血单个核细胞以2×105cells·mL-1的密度接种于RWV培养室内,开启蠕动泵和气泵。培养液以IMDM为基础培养基,添加10%胎牛血清、10%马血清及下列生长因子:SCF 16ng·mL-1,FL 7.47ng·mL-1,TPO7.47ng·mL-1,IL-35.33ng·mL-1,G-CSF 3.33ng·mL-1,GM-CSF 2.13ng·mL-1。反应器的培养室转速经由0rpm一小时,3rpm一小时,5rpm十二小时后,保持在6rpm。Inoculation and cultivation of hematopoietic stem cells in the reactor: turn on the temperature control switch, control the temperature of the main part of the RWV in the heat preservation cover at 37°C, and inoculate the human umbilical cord blood mononuclear cells in the RWV at a density of 2×10 5 cells·mL -1 In the cultivation room, turn on the peristaltic pump and the air pump. The culture medium is based on IMDM, supplemented with 10% fetal bovine serum, 10% horse serum and the following growth factors: SCF 16ng·mL -1 , FL 7.47ng·mL -1 , TPO 7.47ng·mL -1 , IL- 35.33ng·mL -1 , G-CSF 3.33ng·mL -1 , GM-CSF 2.13ng·mL -1 . The incubation chamber rotation speed of the reactor was maintained at 6 rpm after twelve hours via 0 rpm for one hour, 3 rpm for one hour, and 5 rpm for twelve hours.
培养7天,每天取样计有核细胞数,分别在0hr,144hr及197hr进行CD34+细胞流式细胞仪分析以及集落形成(colony-forming unit-granulocyte/macrophage,CFU-GM)能力检测。当检测到培养体系中有核细胞数达到或超过1.5×106cells·mL-1时,抽取部分细胞悬液,同时补加新鲜培养液,使体系中的有核细胞密度不超过这个数值。取出的细胞同样认为仍在反应器中生长,计入扩增倍数。After culturing for 7 days, samples were taken every day to count the number of nucleated cells, and CD34 + cell flow cytometry analysis and colony-forming unit-granulocyte/macrophage (CFU-GM) ability detection were performed at 0hr, 144hr and 197hr respectively. When it is detected that the number of nucleated cells in the culture system reaches or exceeds 1.5×10 6 cells·mL -1 , extract part of the cell suspension and add fresh culture medium at the same time, so that the density of nucleated cells in the system does not exceed this value. Cells taken out were also considered to be still growing in the reactor and included in the expansion factor.
培养结果:人脐带血造血干细胞在RWV培养系统内三维悬浮培养7天后,有核细胞扩增了400多倍,CD34+细胞扩增了30多倍,CFU-GM祖细胞扩增了20多倍。Culture results: after 7 days of three-dimensional suspension culture of human umbilical cord blood hematopoietic stem cells in the RWV culture system, nucleated cells expanded more than 400 times, CD34 + cells expanded more than 30 times, and CFU-GM progenitor cells expanded more than 20 times .
此实施例说明:旋转壁式生物反应器能够给造血干细胞提供优良的三维悬浮生长环境,促进了造血干细胞的扩增;使用此反应器体外培养目的细胞是可行的。This example shows that: the rotating wall bioreactor can provide an excellent three-dimensional suspension growth environment for hematopoietic stem cells, and promote the expansion of hematopoietic stem cells; it is feasible to use this reactor to culture target cells in vitro.
实施例4:Example 4:
本实施例为海藻酸钙微胶珠包埋兔骨髓间充质干细胞静态条件下支持、滋养人脐带血造血干细胞的体外扩增。This example is the in vitro expansion of human umbilical cord blood hematopoietic stem cells supported and nourished by rabbit bone marrow mesenchymal stem cells embedded in calcium alginate microgel beads under static conditions.
为了验证海藻酸钙微胶珠包埋的滋养细胞能够对外部的造血干细胞起到支持、滋养的作用,将海藻酸钙微胶珠包埋的兔骨髓间充质干细胞与人脐带血造血干细胞在六孔培养板中静态条件下进行了共培养。In order to verify that trophoblast cells embedded in calcium alginate microgel beads can support and nourish external hematopoietic stem cells, rabbit bone marrow mesenchymal stem cells embedded in calcium alginate microgel beads and human umbilical cord blood hematopoietic stem cells Co-cultivation was carried out under static conditions in six-well culture plates.
兔骨髓间充质干细胞的分离和培养:取四周龄体重2.5kg左右的新西兰大白兔,注射空气法处死,取出股骨和胫骨,浸泡在75%的酒精中30分钟,转移至无菌超净台内。用骨钳剪开骨两端,PBS冲洗骨髓腔,冲出骨髓。加无血清DMEM培养基稀释,1200rpm离心10分钟。弃脂肪层,加无血清DMEM培养基稀释。然后与Ficoll细胞分离液按1∶1体积比混合,3000rpm离心30分钟。吸取界面层,加入无血清DMEM培养基清洗2次,1200rpm离心5分钟。去上清,加入含20%胎牛血清的DMEM培养基,调整细胞浓度,以5×105cells·cm-2的密度接种于培养瓶中。三天后去除悬浮细胞,每五天半量换液。当原代兔骨髓间充质干细胞在培养瓶底达到80%融合时候,加入浓度为0.05%的胰酶(含0.02%EDTA)消化,按1∶3的比例进行传代培养。Isolation and culture of rabbit bone marrow mesenchymal stem cells: New Zealand white rabbits weighing about 2.5kg at four weeks old were killed by air injection, femur and tibia were taken out, soaked in 75% alcohol for 30 minutes, and transferred to a sterile ultra-clean bench Inside. Cut both ends of the bone with bone forceps, rinse the bone marrow cavity with PBS, and flush out the bone marrow. Add serum-free DMEM medium to dilute, and centrifuge at 1200rpm for 10 minutes. Discard the fat layer and add serum-free DMEM medium to dilute. Then it was mixed with Ficoll cell separation solution at a volume ratio of 1:1, and centrifuged at 3000 rpm for 30 minutes. Aspirate the interface layer, add serum-free DMEM medium to wash twice, and centrifuge at 1200rpm for 5 minutes. Remove the supernatant, add DMEM medium containing 20% fetal calf serum, adjust the cell concentration, and inoculate in a culture flask at a density of 5×10 5 cells·cm -2 . After three days, the suspended cells were removed, and the medium was changed every five days in half. When the primary rabbit bone marrow mesenchymal stem cells reached 80% confluence at the bottom of the culture flask, they were digested with 0.05% trypsin (containing 0.02% EDTA) and subcultured at a ratio of 1:3.
海藻酸钙微胶珠包埋兔骨髓间充质干细胞:制备密度为2.5×105cells·mL-1的第四代兔骨髓间充质干细胞悬液,与1.5%的海藻酸钠溶液以1∶4体积比混合均匀,经5#针头逐滴滴加到1.5%氯化钙溶液中,不断搅拌,反应10分钟,用筛网过滤得到微胶珠,PBS洗涤三次,得到直径为2毫米的包埋有兔骨髓间充质干细胞的海藻酸钙微胶珠。Calcium alginate microgel beads embedding rabbit bone marrow mesenchymal stem cells: prepare the fourth-generation rabbit bone marrow mesenchymal stem cell suspension with a density of 2.5×10 5 cells·mL -1 , mix with 1.5% sodium alginate solution at 1 : 4 volume ratio mixed evenly, dropwise added to 1.5% calcium chloride solution through a 5 # needle, stirred constantly, reacted for 10 minutes, filtered with a sieve to obtain microgel beads, washed three times with PBS, and obtained a diameter of 2 mm. Calcium alginate microgel beads embedded with rabbit bone marrow mesenchymal stem cells.
人脐带血单个核细胞的分离:同实施例3。Separation of human umbilical cord blood mononuclear cells: same as in Example 3.
六孔培养板中兔骨髓间充质干细胞与人脐带血单个核细胞共培养:将包埋兔骨髓间充质干细胞的微胶珠按每孔30个分配于6孔培养板中与密度为3×105cells·mL-1的人脐带血单个核细胞混合,置在37℃,5%CO2培养箱中培养。培养液以IMDM为基础培养基,添加20%FBS,并补充下列低剂量的生长因子,SCF 16ng·mL-1,FL 7.47ng·mL-1,TPO 7.47ng·mL-1,IL-3 5.33ng·mL-1,G-CSF3.33ng·mL-1,GM-CSF 2.13ng·mL-1。Co-cultivation of rabbit bone marrow mesenchymal stem cells and human umbilical cord blood mononuclear cells in a six-well culture plate: distribute microgel beads embedding rabbit bone marrow mesenchymal stem cells in a 6-well culture plate at a density of 3 Human umbilical cord blood mononuclear cells × 10 5 cells·mL -1 were mixed and cultured in a 37°C, 5% CO 2 incubator. The culture medium is based on IMDM, supplemented with 20% FBS, and supplemented with the following low-dose growth factors, SCF 16ng·mL -1 , FL 7.47ng·mL -1 , TPO 7.47ng·mL -1 , IL-3 5.33 ng·mL -1 , G-CSF 3.33 ng·mL -1 , GM-CSF 2.13 ng·mL -1 .
初始时微胶珠包埋的兔骨髓间充质干细胞与微胶珠外人脐带血单个核细胞数量之比约为4∶100,即间充质干细胞与CD34+细胞之比约为4∶1(初始时CD34+细胞约占单个核细胞的1%),每孔添加2mL培养液。每天换液10%,计有核细胞密度,并分别在0hr,72hr,120hr以及168hr进行CD34+细胞流式细胞仪分析及CFU-GM集落检测。Initially, the ratio of the number of rabbit bone marrow mesenchymal stem cells embedded in microgel beads to the number of human umbilical cord blood mononuclear cells outside the microgel beads was about 4:100, that is, the ratio of mesenchymal stem cells to CD34 + cells was about 4:1 ( Initially, CD34 + cells accounted for about 1% of mononuclear cells), and 2 mL of culture medium was added to each well. 10% of the medium was changed every day, and the density of nucleated cells was counted, and CD34 + cell flow cytometry analysis and CFU-GM colony detection were carried out at 0hr, 72hr, 120hr and 168hr respectively.
培养结果:在七天的培养过程中,共培养体系中有核细胞、CD34+细胞以及CFU-GM扩增倍数分别达到9倍、20倍和9倍。图7为此共培养体系培养至168hr时的显微照片(A:100×;B:200×)。Culture results: During the seven-day culture process, the expansion times of nucleated cells, CD34 + cells and CFU-GM in the co-culture system reached 9 times, 20 times and 9 times respectively. Fig. 7 is a photomicrograph (A: 100×; B: 200×) of the co-culture system cultured to 168 hours.
此实施例说明:海藻酸钙微胶珠是一种有效的细胞共培养手段,能够起到免疫隔离的作用,并且有利于共培养后间充质干细胞和造血干细胞的分离;包埋在微胶珠中的兔骨髓间充质干细胞能够在体外静态条件下有效地支持人脐带血造血干/祖细胞的扩增,说明使用微胶珠包埋滋养细胞并没有阻碍这种滋养作用;如果配合RWV培养系统的三维悬浮生长环境,微胶珠包埋滋养细胞将能够更好地支持、滋养造血干细胞的体外扩增。This example shows that: calcium alginate microgel beads are an effective means of co-cultivation of cells, can play a role in immune isolation, and are beneficial to the separation of mesenchymal stem cells and hematopoietic stem cells after co-culture; Rabbit bone marrow mesenchymal stem cells in beads can effectively support the expansion of human umbilical cord blood hematopoietic stem/progenitor cells under static conditions in vitro, indicating that the use of microgel beads to embed trophoblast cells does not hinder this trophobic effect; if combined with RWV The three-dimensional suspension growth environment of the culture system, microgel beads embedded trophoblasts will be able to better support and nourish the in vitro expansion of hematopoietic stem cells.
实施例5:Example 5:
本实施例为海藻酸钙微胶珠包埋兔骨髓间充质干细胞动态条件下支持、滋养人脐带血造血干细胞的体外扩增。This example is the in vitro expansion of human umbilical cord blood hematopoietic stem cells supported and nourished by rabbit bone marrow mesenchymal stem cells embedded in calcium alginate microgel beads under dynamic conditions.
为了验证海藻酸钙微胶珠包埋的滋养细胞能够对外部的造血干细胞起到支持、滋养的作用,将海藻酸钙微胶珠包埋的兔骨髓间充质干细胞与人脐带血造血干细胞在旋转壁式生物反应器内动态条件下进行了共培养。In order to verify that trophoblast cells embedded in calcium alginate microgel beads can support and nourish external hematopoietic stem cells, rabbit bone marrow mesenchymal stem cells embedded in calcium alginate microgel beads and human umbilical cord blood hematopoietic stem cells Co-cultivation was carried out under dynamic conditions in a rotating wall bioreactor.
兔骨髓间充质干细胞的分离和培养:同实施例4。Isolation and cultivation of rabbit bone marrow mesenchymal stem cells: same as in Example 4.
海藻酸钙微胶珠包埋兔骨髓间充质干细胞:同实施例4。Calcium alginate microgel beads embed rabbit bone marrow mesenchymal stem cells: the same as in Example 4.
人脐带血单个核细胞的分离:同实施例3。Separation of human umbilical cord blood mononuclear cells: same as in Example 3.
实验前生物反应器的准备:同实施例3。Preparation of the bioreactor before the experiment: same as Example 3.
旋转壁式生物反应器内兔骨髓间充质干细胞与人脐带血单个核细胞共培养:打开温控开关控制保温罩内RWV主体部分温度在37℃,将450个包埋兔骨髓间充质干细胞的海藻酸钙微胶珠与密度为3×105cells·mL-1人脐带血单个核细胞接种于RWV培养室内,开启蠕动泵和气泵。培养液以IMDM为基础培养基,添加下列生长因子:SCF 16ng·mL-1,FL 7.47ng·mL-1,TPO 7.47ng·mL-1,IL-35.33ng·mL-1,G-CSF 3.33ng·mL-1,GM-CSF 2.13ng·mL-1。反应器的培养室转速经由0rpm一小时,3rpm一小时,5rpm十二小时后,保持在6rpm。Co-culture of rabbit bone marrow mesenchymal stem cells and human umbilical cord blood mononuclear cells in a rotating wall bioreactor: turn on the temperature control switch to control the temperature of the main part of the RWV in the heat preservation cover at 37°C, and embed 450 rabbit bone marrow mesenchymal stem cells Calcium alginate microgel beads and human umbilical cord blood mononuclear cells with a density of 3×10 5 cells·mL -1 were inoculated in the RWV culture chamber, and the peristaltic pump and air pump were turned on. The culture medium is based on IMDM, and the following growth factors are added: SCF 16ng·mL -1 , FL 7.47ng·mL -1 , TPO 7.47ng·mL -1 , IL-35.33ng·mL -1 , G-CSF 3.33 ng·mL -1 , GM-CSF 2.13ng·mL -1 . The incubation chamber rotation speed of the reactor was maintained at 6 rpm after twelve hours via 0 rpm for one hour, 3 rpm for one hour, and 5 rpm for twelve hours.
培养7天,每天取样计有核细胞数,分别在0hr,144hr及197hr进行CD34+细胞流式细胞仪分析以及CFU-GM检测。当检测到培养体系中有核细胞数达到或超过1.5×106cells·mL-1时,抽取部分细胞悬液,同时补加新鲜培养液,使体系中的有核细胞密度不超过这个数值。取出的细胞同样认为仍在反应器中生长,计入扩增倍数。共培养结束后,分离造血细胞和微胶珠。再将包埋兔骨髓间充质干细胞的微胶珠用PBS冲洗三次,浸泡在55mM的柠檬酸钠溶液中,反应10分钟,收获兔骨髓间充质干细胞,接种至培养瓶中培养。After culturing for 7 days, samples were taken every day to count the number of nucleated cells, and CD34 + cell flow cytometry analysis and CFU-GM detection were performed at 0hr, 144hr and 197hr respectively. When it is detected that the number of nucleated cells in the culture system reaches or exceeds 1.5×10 6 cells·mL -1 , extract part of the cell suspension and add fresh culture medium at the same time, so that the density of nucleated cells in the system does not exceed this value. Cells taken out were also considered to be still growing in the reactor and included in the expansion factor. After co-cultivation, hematopoietic cells and beads were isolated. The microgel beads embedding rabbit bone marrow mesenchymal stem cells were washed three times with PBS, soaked in 55mM sodium citrate solution, reacted for 10 minutes, harvested rabbit bone marrow mesenchymal stem cells, inoculated into culture flasks for culture.
培养结果:在七天的培养过程中,共培养体系中有核细胞、CD34+细胞以及CFU-GM扩增倍数分别达到170倍、24倍和14倍。滋养细胞——兔骨髓间充质干细胞破囊收获率达到约90%。Culture results: During the seven-day culture process, the expansion times of nucleated cells, CD34 + cells and CFU-GM in the co-culture system reached 170 times, 24 times and 14 times, respectively. Trophoblastic cells—the harvest rate of rabbit bone marrow mesenchymal stem cells reached about 90%.
此实施例说明:在旋转壁式生物反应器中包埋在海藻酸钙微胶珠中的兔间充质干细胞有效地滋养、支持了造血干细胞的体外扩增。尽管本实施例中造血干细胞的扩增倍数不及实施例3中的高,但本实施例中使用包埋滋养细胞替代了动物血清,更加靠近临床,更加具有医学价值。This example illustrates that rabbit mesenchymal stem cells embedded in calcium alginate microgel beads in a rotating wall bioreactor effectively nourish and support the in vitro expansion of hematopoietic stem cells. Although the expansion factor of hematopoietic stem cells in this example is not as high as that in Example 3, the embedded trophoblasts are used instead of animal serum in this example, which is closer to clinical practice and has more medical value.
尽管本发明是以兔骨髓间充质干细胞滋养人脐带血来源的造血干细胞为例来描述的,但这种描述并不意味着对本发明构成限制。参照本发明的描述,其它种类的滋养细胞、被滋养细胞以及实施例的其他变形,对于本领域技术人员都是可以预料的。因此,这样的变形不会脱离所属权利要求限定的范围及精神。Although the present invention is described by taking rabbit bone marrow mesenchymal stem cells nourishing hematopoietic stem cells derived from human umbilical cord blood as an example, this description does not mean to limit the present invention. With reference to the description of the present invention, other types of trophoblasts, trophoblasts and other modifications of the embodiments are expected by those skilled in the art. Therefore, such modifications do not depart from the scope and spirit defined by the appended claims.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100768613A CN100384987C (en) | 2006-04-17 | 2006-04-17 | A method for expanding hematopoietic stem cells under three-dimensional conditions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100768613A CN100384987C (en) | 2006-04-17 | 2006-04-17 | A method for expanding hematopoietic stem cells under three-dimensional conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1837358A CN1837358A (en) | 2006-09-27 |
CN100384987C true CN100384987C (en) | 2008-04-30 |
Family
ID=37014866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100768613A Expired - Fee Related CN100384987C (en) | 2006-04-17 | 2006-04-17 | A method for expanding hematopoietic stem cells under three-dimensional conditions |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100384987C (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102465112A (en) * | 2010-11-01 | 2012-05-23 | 张正前 | Human umbilical cord blood hematopoietic stem cell in-vitro efficient amplification technology |
CN102965330B (en) * | 2011-09-01 | 2014-07-09 | 中国科学院大连化学物理研究所 | Method for synergistic growth of multiple cells |
CN102747029B (en) * | 2012-07-30 | 2013-09-25 | 何伟 | Culture method for retina progenitor cells and culture medium thereof |
CN103122348A (en) * | 2012-09-20 | 2013-05-29 | 天津卫凯生物工程有限公司 | Islet microcapsules, islet model, preparation method and application |
CN103881908A (en) * | 2012-12-20 | 2014-06-25 | 中国科学院大连化学物理研究所 | Bioreactor system for cell co-cultivation |
CN104667348B (en) * | 2015-02-04 | 2016-03-02 | 北京大学第三医院 | A kind of Pharmaceutical composition containing sodium alginate and preparation method thereof |
CN105132365A (en) * | 2015-08-17 | 2015-12-09 | 深圳华毓造血干细胞研究有限公司 | Three-dimensional induction culture method of mesenchymal stem cells |
CN106801038A (en) * | 2015-11-26 | 2017-06-06 | 中国人民解放军军事医学科学院基础医学研究所 | A kind of utilization Three-dimensional cell culture system promotes the cell culture processes of umbilical cord blood hematopoietic stem cell fast and stable propagation |
CN111321117A (en) * | 2018-12-13 | 2020-06-23 | 陈传果 | Method for three-dimensional culture and expansion of hematopoietic stem cells |
CN113583947B (en) * | 2020-04-30 | 2023-06-09 | 同济大学 | Method and system for culturing mesenchymal stem cells and hematopoietic stem cells in vitro |
CN114591910B (en) * | 2022-03-28 | 2023-11-21 | 重庆市铂而斐细胞生物技术有限公司 | Method for enriching cord blood hematopoietic stem cells by utilizing mesenchymal stem cells cultured in low-oxygen three-dimensional environment |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6010696A (en) * | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
CN1280187A (en) * | 1999-07-13 | 2001-01-17 | 中国人民解放军第二军医大学 | Method of extracorporeal cloning hemopoietic stem cell |
CN1415747A (en) * | 2002-11-23 | 2003-05-07 | 浙江大学 | Technique for co-culturing and amplifying hemopoietic stem/progenitor cell in vitro by stages |
CN1542122A (en) * | 2003-11-07 | 2004-11-03 | 大连理工大学 | Rotary Cell Culture System |
US6911201B1 (en) * | 1999-02-04 | 2005-06-28 | Technion Research & Development Foundation Ltd. | Method of producing undifferentiated hemopoietic stem cells using a stationary phase plug-flow bioreactor |
-
2006
- 2006-04-17 CN CNB2006100768613A patent/CN100384987C/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6010696A (en) * | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
US6911201B1 (en) * | 1999-02-04 | 2005-06-28 | Technion Research & Development Foundation Ltd. | Method of producing undifferentiated hemopoietic stem cells using a stationary phase plug-flow bioreactor |
CN1280187A (en) * | 1999-07-13 | 2001-01-17 | 中国人民解放军第二军医大学 | Method of extracorporeal cloning hemopoietic stem cell |
CN1415747A (en) * | 2002-11-23 | 2003-05-07 | 浙江大学 | Technique for co-culturing and amplifying hemopoietic stem/progenitor cell in vitro by stages |
CN1542122A (en) * | 2003-11-07 | 2004-11-03 | 大连理工大学 | Rotary Cell Culture System |
Non-Patent Citations (6)
Title |
---|
人胎盘间充质干细胞的分离鉴定及其对脐血造血干/祖细胞体外扩增的支持作用. 李长东,53-70,吉林大学博士学位论文. 2004 |
人胎盘间充质干细胞的分离鉴定及其对脐血造血干/祖细胞体外扩增的支持作用. 李长东,53-70,吉林大学博士学位论文. 2004 * |
人骨髓间充质干细胞对脐血干细胞体外扩增支持作用的研究. 费小明,陆化,吴雨洁等.南京医科大学学报(自然科学版),第24卷第3期. 2004 |
人骨髓间充质干细胞对脐血干细胞体外扩增支持作用的研究. 费小明,陆化,吴雨洁等.南京医科大学学报(自然科学版),第24卷第3期. 2004 * |
骨髓间充质干细胞与造血干细胞共培养对脐血造血干细胞扩增的作用. 王金福,王立娟,Jenny,Harrintong等.浙江大学学报(理学版),第30卷第1期. 2003 |
骨髓间充质干细胞与造血干细胞共培养对脐血造血干细胞扩增的作用. 王金福,王立娟,Jenny,Harrintong等.浙江大学学报(理学版),第30卷第1期. 2003 * |
Also Published As
Publication number | Publication date |
---|---|
CN1837358A (en) | 2006-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100384987C (en) | A method for expanding hematopoietic stem cells under three-dimensional conditions | |
EP3848454B1 (en) | Live cell constructs for production of cultured milk product and methods using the same | |
US7122371B1 (en) | Modular cell culture bioreactor | |
US20030232432A1 (en) | Growth of human Mesenchymal Stem Cells (hMSC) using umbilical cord blood serum and the method for the peparation thereof | |
CA2657013A1 (en) | Temperature-responsive microcarrier | |
CN102205147B (en) | Transplanting material of fat granule tissues compounded with SVFs (Stromal Vascular Fractions) and PRFs (Platelet-Rich Fibrins) as well as preparation method thereof | |
CN102296029A (en) | perfusion bioreactor system | |
JP2012506257A (en) | Perfusion bioreactor, cell culture system, and method for production of cells and cell derived products | |
EP1999250B1 (en) | Method of cultivation of human mesenchymal stem cells, particularly for the treatment of non-healing fractures, and bioreactor for carrying out this cultivation method | |
CN108410797A (en) | The expanding stem cells in hollow-fiber bioreactor | |
CN106754668A (en) | A kind of stem cell medium and parenteral solution | |
CN101508975A (en) | Method for supporting, regulating and controlling amplification of hematopoietic stem/progenitor cell in vitro with microencapsulation osteoblast in hypoxia condition | |
WO2019161590A1 (en) | Mesenchymal stem cell suspension and preparation method therefor and application thereof | |
Scibona et al. | Expansion processes for cell-based therapies | |
CN108396007B (en) | A method for constructing a three-dimensional model of the blood-milk barrier of dairy cows in vitro | |
CN112342190A (en) | Method for improving exosome yield of mesenchymal stem cells and application thereof | |
EP2130905A1 (en) | Method for culturing eukaryotic cells | |
CN106606512B (en) | A kind of mixed cell preparation for treating myocardial infarction and preparation method and application | |
CN115478048A (en) | Preparation of exosome by culturing adipose-derived mesenchymal stem cells | |
CN110283785A (en) | A kind of method that gamma delta T-NK cell co-cultures | |
CN114045253A (en) | Stem cell and islet beta cell co-culture method based on composite hydrogel | |
CN108034634B (en) | Method for separating endometrial mesenchymal stem cells from menstrual blood | |
CN112501115B (en) | A method for extracting, separating and purifying rabbit muscle stem cells | |
CN1118563C (en) | Hematopoietic device using hollow fibre to simulate bone marrow | |
CN115992091A (en) | Separation and culture method of rat bone marrow mesenchymal stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080430 Termination date: 20110417 |